Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients

Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients is a phase 3, randomised interventional study registered as NCT04980716 by Sun Yat-sen University, with a registry enrolment figure of 524 participants, started 2021-06-01 and due to reach its primary completion in 2026-01-31. Interventions recorded: Multiple cardiovascular drugs related to "Golden Triangle". Conditions listed: Non-small Cell Lung Cancer; Cardiovascular Complication. Primary outcome: Overall survival; The incidence of grade 2+ cardiotoxicity events. Lung eligibility wording from the registry: "It is diagnosed as non-small cell lung cancer by pathological examination or cytological examination; it is assessed as locally advanced, unresectable stage III non-small cell lung cancer by imaging;". Sites: China. No results are recorded here; the registry entry is the source.